Digestive and breast cancer patients managed during the first wave of COVID-19 pandemic: Short and middle term outcomes

Table 2 Patient comorbidities ordered by cancer type group

n (%)	CR, n = 53	HBP, n = 13	OG, n = 9	Breast, n = 16
Smoker	5 (9.4)	2 (15.4)	2 (22.2)	3 (18.8)
Chronic kidney disease (moderate/severe)	7 (13.2)	1 (7.7)	2 (22.2)	1 (6.3)
Chronic obstructive pulmonary disease	1 (1.9)	1 (7.7)	0	0
Asthma	1 (1.9)	1 (7.7)	1 (11.1)	0
Congenital abnormality - cardiac	1 (1.9)	0	0	0
Hypertension	29 (54.7)	5 (38.5)	6 (66.7)	7 (43.8)
Congestive heart failure	6 (11.3)	1 (7.7)	0	0
Ischemic heart disease	4 (7.5)	1 (7.7)	0	0
Peripheral vascular disease	2 (3.8)	0	0	0
Stroke/TIA	4 (7.5)	1 (7.7)	0	1 (6.3)
Dementia	1 (1.9)	0	0
Diabetes mellitus	15 (28.3)	3 (23.1)	2 (22.2)	1 (6.3)
HIV infection	0	0	0	0
Others	39 (73.6)1	8 (61.5)2	6 (66.7)3	11 (68.8)4

¹Atrial fibrilation (6 patients), Previous cancer (6), Cardiac valvular disease (4), Obstructive sleep apnea (3), Pulmonary hypertension (2), Pulmonary fibrosis (1), Liver cirrhosis with portal hypertension (1).

²Previous cancer (3), Pulmonary hypertension (1).

³Mitral insufficiency (1).

⁴Previous breast cancer (1), Previous colorectal and thyroid cancer (1).

CR: Colorectal; HBP: Hepato-Bilio-Pancreatic; OG: Oesophago-Gastric.